A paper published today in a prominent medical journal asserts that the law governing dietary supplements is no longer adequate to protect consumers and sweeping changes are needed to keep potentially dangerous new ingredients off the market.
By Steve Mister, President & CEO, Council for Responsible Nutrition
The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.
More than 40% of dietary supplements may not be as effective as touted to be, after 100 products tested by Japan’s National Consumer Affairs Center (NCAC) were unable to dissolve in water within the specified time limits.
By Michael McGuffin, president, American Herbal Products Association
Questions surrounding the hemp/CBD trade, a recognition of the continued popularity of herbal supplements, and a casting a wary eye toward regulatory creep topped the list of 2019 concerns for the American Herbal Products Association.
CBDepot has applied for Novel Food (NF) application for a synthetic form of cannabidiol (CBD) for food supplement use in a move the firm says has a better chance of regulatory approval.
A call from FDA to consumers to avoid products recalled as part of an enforcement action underscores how difficult it can be to get offending articles off the market.
An interim federal government funding measure does not include language creating a legal pathway for hemp/CBD products, despite advocacy on the part of stakeholders including lawmakers and trade organizations.
Recent statements and actions by the US Food and Drug Administration (FDA) regarding CBD have spurred four of the dietary supplement industry’s trade association to write Congress urging them to take quick action.
New York State recently put into place regulations that govern hemp cultivation within its borders. In addition, the new law creates a regulatory framework specific to the trade in cannabinoid extracts and finished goods.
It was only a matter of time before the plaintiff’s bar sought to cash in on the legal uncertainty surrounding cannabidiol (CBD), say attorneys. So how might brands defend themselves against the latest wave of lawsuits, which argue that their products...
A recent review of astaxanthin found evidence to support the safety of dosages of 12 mg up to 24 mg a day. But that applies to only to natural astaxanthin, not to the synthetic forms, the authors said.
The European Specialist Sports Nutrition Alliance (ESSNA) today reveals a manifesto, in which it looks to match consumers with products that complement balanced diets and support active lifestyles.
A recent appellate court decision coupled with a spate of warning letters sets the stage for more class action lawsuits like the proposed ones filed against CBD companies this week, experts say.
An upcoming webinar will explore the taxonomic changes to the genus Lactobacillus and the implications for brands, from labeling to consumer education.
Hemp-derived CBD brands Charlotte’s Web and Infinite Product Co. have both been hit with proposed class action lawsuits filed in California that allege they misled consumers by marketing their products as dietary supplements when FDA has specifically...
A leading nutritionist is calling for greater awareness of vitamin D deficiency in younger healthy populations that are becoming susceptible to an increased diabetes risk as a result.
The UFC Anti-Doping Policy now includes a definition of certified supplements to help athletes steer clear of contaminated substances and recognize the value of third-party supplement certification.
While penning 15 warning letters about CBD in one day (more than the FDA has sent in three years) attracted a lot of media attention, does it signal a change in enforcement priorities for the agency, which has repeatedly warned that cannabidiol is not...
Sparked by proposed US Department of Agriculture regulations that would drastically alter the certification process for industrial hemp, two lawmakers from Oregon want the agency to make several changes before it finalizes rules for the US Domestic Hemp...
The US Food and Drug Administration has stated that it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS) for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”.
Pressure continues to build to find a resolution to the CBD impasse. A trade organization and a state government have filed notices with FDA on the issue.
Europe’s Food Safety Authority (EFSA) rules scientific evidence pointing to a white kidney bean extract’s link with body weight reduction as “insufficient,” after the applicant cites application process inconsistencies.
The turmoil surrounding the CBD question has obscured other important debates, such as how to alter DHSEA is such a way that more scientific information can be conveyed to consumers.
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
Introducing user fees for the food industry – of which dietary supplements are a subset – is a tough proposition, says Dan Fabricant, president and CEO of the Natural Products Association.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
As online influencers continue to wield more and more financial power, the FTC is laying down the rules on how brands and influencers must be transparent about their working relationship.
Australia’s national regulator, the Therapeutic Goods Administration (TGA), is proposing to classify non-food appropriate sports supplements as therapeutic goods.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
Cara Welch, PhD has been named deputy director of the Office of Dietary Supplements. Welch replaces Bob Durkin, who recently left FDA for a private law practice.
Before rushing into an amendment of DSHEA it’s wise to consider how the law has already been modified and how full enforcement of those provisions might accomplish what the modification advocates have in mind, a trade organization cautions.
A booming global market with double digit growth rates, establishing an adequate intake for dietary microbes, and why the impending taxonomic changes to the genus Lactobacillus are like Y2K: These were just some of the topics covered during the fourth...
The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.
Legislative challenges to dietary supplements and opportunities for regulatory fine tuning continue even as the industry is distracted, said Steve Mister of CRN.
The United States Department of Agriculture has issued its eagerly anticipated draft rule on hemp cultivation. The rule is viewed as largely consistent with many of the state rules already in place.
A vast and growing majority of American companies doing business in China have been negatively affected by the US-China trade war, an expert on the matter said at a recent meeting.
FDA warned pregnant and breast-feeding women yesterday to avoid CBD, THC and marijuana in any form, including the proliferation of food, supplements and cosmetics containing CBD and other cannabis-derived ingredients that currently are flooding the market...
NFL player Brandon Copeland, who had been suspended over a failed drug test, said he plans to file a lawsuit against a company that he claims gave him "contaminated" supplements.
New Trump Administration executive orders on guidance documents from regulatory agencies likely will affect the dietary supplement industry, an attorney says.
Early data on the Food Safety Modernization Act suggests the new law is working as compliance is improving and recalls have hit a five year low. A newly launched web portal will help track that data.
The International Probiotics Association will host its fourth IPA DC Workshop with insights from a range of experts and stakeholders, including the FDA/ CFSAN, FTC, and Health Canada. The event is held in conjunction with the US Pharmacopeia.
